JULIA IRWIN: Open Payments
NPI 1306951124 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 194 payments from 16 companies in 2025. Trend: 2023 $2,672 · 2024 $2,970 · 2025 $3,062
Food & beverage: $2,950Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $452 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $412 |
| Lundbeck LLC | 18 | $338 |
| Neurocrine BioSciences, Inc. | 16 | $323 |
| Otsuka America Pharmaceutical, Inc. | 20 | $267 |
| Alkermes, Inc. | 11 | $252 |
| Vanda Pharmaceuticals Inc. | 12 | $185 |
| Teva Pharmaceuticals USA, Inc. | 4 | $180 |
| Janssen Pharmaceuticals, Inc | 12 | $164 |
| Almatica Pharma LLC | 8 | $135 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, LYBALVI, FANAPT, LOREEV XR.
Industry payments across OK — which companies pay providers there.
